Davide Rosati

Dr. Davide Rosati

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
DRDavide Rosati
Davide Rosati
CRChiara Rosato
Chiara Rosato
GPGiulio Pagliuca
Giulio Pagliuca
BCBruna Cerbelli
Bruna Cerbelli
CRCarlo Della Rocca
Carlo Della Rocca
AGAndrea Gallo
Andrea Gallo

28 December 2019 in World Journal of Gastroenterology
Verified
Journal Article
Open access
SNSilvia Nardelli
Silvia Nardelli
OROliviero Riggio
Oliviero Riggio
DRDavide Rosati
Davide Rosati
SGStefania Gioia
Stefania Gioia
AFAlessio Farcomeni
Alessio Farcomeni
LRLorenzo Ridola
Lorenzo Ridola
Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms

29 October 2015 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
Antonio GrecoAntonio Greco
Antonio Greco
AVArmando De Virgilio
Armando De Virgilio
MRMaria Ida Rizzo
Maria Ida Rizzo
FPFabio Pandolfi
Fabio Pandolfi
DRDavide Rosati
Davide Rosati
MVMarco de Vincentiis
Marco de Vincentiis

14 March 2018 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
Umberto Vespasiani-GentilucciUmberto Vespasiani-Gentilucci
Umberto Vespasiani-Gentilucci
CDChiara Dell’unto
Chiara Dell’unto
AVAntonio De Vincentis
Antonio De Vincentis
ABAndrea Baiocchini
Andrea Baiocchini
MMMarco Delle Monache
Marco Delle Monache
APAntonio Picardi
Antonio Picardi
Background & Aims. Identifying NAFLD patients at risk of progression is crucial to orient medical care and resources. We aimed to verify if the effects determined by different single nucleotide polymorphisms (SNPs) could add up to multiply the risk of NAFLD and NASH-cirrhosis. Methods. Three study populations, that is, patients diagnosed with NASH-cirrhosis or with noncirrhotic NAFLD and healthy controls, were enrolled. PNPLA3 rs738409, TM6SF2 rs58542926, KLF6 rs3750861, SOD2 rs4880, and LPIN1 rs13412852 were genotyped. Results. One hundred and seven NASH-cirrhotics, 93 noncirrhotic NAFLD, and 90 controls were enrolled. At least one difference in allele frequency between groups was significant, or nearly significant, for the PNPLA3, TM6SF2, and KLF6 variants (p<0.001, p<0.05, and p=0.06, resp.), and a risk score based on these SNPs was generated. No differences were observed for SOD2 and LPIN1 SNPs. When compared to a score of 0, a score of 1-2 quadrupled, and a score of 3-4 increased 20-fold the risk of noncirrhotic NAFLD; a score of 3-4 quadrupled the risk of NASH-cirrhosis. Conclusions. The effects determined by disease-associated variants at different loci can add up to multiply the risk of NAFLD and NASH-cirrhosis. Combining different disease-associated variants may represent the way for genetics to keep strength in NAFLD diagnostics.

1 October 2016 in Acta Otorhinolaryngologica Italica
Verified
Journal Article
Open access
AVArmando De Virgilio
Armando De Virgilio
Antonio GrecoAntonio Greco
Antonio Greco
FBFrancesco Bussu
Francesco Bussu
AGA. Gallo
A. Gallo
DRDavide Rosati
Davide Rosati
MVM. De Vincentiis
M. De Vincentiis
Lo scopo del presente studio è stato quello di valutare l’efficacia oncologica della laringectomia totale di salvataggio in pazienti precedentemente sottoposti a laringectomia subtotale open o microchirurgia laser transorale affetti da carcinoma squamocellulare laringeo. Abbiamo analizzato retrospettivamente le informazioni cliniche, chirurgiche e patologiche di 35 pazienti sottoposti a laringectomia totale di salvataggio dopo recidiva di carcinoma laringeo (laringectomia subtotale open o transorale). Le informazioni sono state analizzate tramite l’utilizzo delle curve di Kaplan-Meier nonché tramite l’analisi univariata e multivariata dei fattori prognostici. Non sono emerse differenze statisticamente significative nel confronto tra il gruppo di pazienti precedentemente sottoposti a laringectomia subtotale ed il gruppo sottoposto a microchirurgia laser transorale sia in termini di overall survival (OS) e disease specific survival (DSS) a 3 anni (OS = 38% vs 52%, p = 0,16; DSS = 40% vs 61%, p = 0,057) che di controllo locoregionale (LRC) a 2 anni (LRC = 40% vs 54%, p = 0,056). È stata tuttavia messa in evidenza una tendenza che indica una sopravvivenza e controllo locoregionale peggiore nei pazienti sottoposti a laringectomia subtotale. La conservazione dello scheletro osteocartilagineo della microchirurgia laser transorale si traduce ipoteticamente in una maggiore probabilità di salvataggio delle recidive anteriori con diffusione extralaringea.

4 December 2019 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
Antonio MinniAntonio Minni
Antonio Minni
DRDavide Rosati
Davide Rosati
CCCarlo Cavaliere
Carlo Cavaliere
Massimo RalliMassimo Ralli
Massimo Ralli
GSGiulio Sementilli
Giulio Sementilli
MBMarco Bononi
Marco Bononi
Background: Total thyroidectomy (TT) and completion thyroidectomy (CT) are two common surgical operations that are frequently followed by vocal symptoms despite preservation of the recurrent laryngeal nerve (RLN) and of the external branch of superior laryngeal nerve (EBSLN). The aim of this study was to analyze vocal alterations through endoscopic findings, videolaryngostroboscopy (VLS), acoustic vocal parameters and impact on patients’ quality of life after surgery in the absence of laryngeal nerve injury. Methods: We enrolled 198 patients who underwent thyroidectomy by the same surgeon. One hundred twenty-six patients underwent TT (group TT) while 72 underwent CT (group CT). All patients underwent preoperative VLS and Voice Handicap Index (VHI) assessment and postoperative VHI, VLS and Acoustic Voice Analysis with Multidimensional Voice Program Analysis 12 to 18 months after surgery. Results: We observed a statistically significant higher rate of EBSLN injury in CT compared to TT. Even in the absence of RLN and EBSLN injury, patients who underwent TT and CT presented slightly worse acoustic vocal parameters and VHI scores compared to healthy controls. Interestingly, some acoustic vocal parameters and VHI scores were significantly worse in group CT compared to group TT. Conclusions: The higher rate of EBSLN injury in CT rather than in TT suggests a higher surgical risk in CT. The vocal parameters of loudness and self-perception of voice were significantly worse after CT, suggesting a larger trauma in patients’ vocal outcome in CT if compared to TT, although these alterations were not reported as psychologically limiting daily life of patients. Nevertheless, the existence of multiple factors contributing to vocal alterations after thyroidectomy highlight the importance of a routine comprehensive functional voice analysis before and after surgery.